Literature DB >> 9405681

Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.

P M Oliver1, J E Fox, R Kim, H A Rockman, H S Kim, R L Reddick, K N Pandey, S L Milgram, O Smithies, N Maeda.   

Abstract

Natriuretic peptides, produced in the heart, bind to the natriuretic peptide receptor A (NPRA) and cause vasodilation and natriuresis important in the regulation of blood pressure. We here report that mice lacking a functional Npr1 gene coding for NPRA have elevated blood pressures and hearts exhibiting marked hypertrophy with interstitial fibrosis resembling that seen in human hypertensive heart disease. Echocardiographic evaluation of the mice demonstrated a compensated state of systemic hypertension in which cardiac hypertrophy and dilatation are evident but with no reduction in ventricular performance. Nevertheless, sudden death, with morphologic evidence indicative in some animals of congestive heart failure and in others of aortic dissection, occurred in all 15 male mice lacking Npr1 before 6 months of age, and in one of 16 females in our study. Thus complete absence of NPRA causes hypertension in mice and leads to cardiac hypertrophy and, particularly in males, lethal vascular events similar to those seen in untreated human hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405681      PMCID: PMC25105          DOI: 10.1073/pnas.94.26.14730

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Heart failure from the point of view of quantitative anatomy.

Authors:  A J LINZBACH
Journal:  Am J Cardiol       Date:  1960-03       Impact factor: 2.778

2.  Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells.

Authors:  B H Koller; L J Hagemann; T Doetschman; J R Hagaman; S Huang; P J Williams; N L First; N Maeda; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Impaired release of atrial natriuretic factor in NaCl-loaded spontaneously hypertensive rats.

Authors:  H K Jin; Y F Chen; R H Yang; Q C Meng; S Oparil
Journal:  Hypertension       Date:  1988-06       Impact factor: 10.190

4.  Premature mortality from coronary heart disease. The Framingham study.

Authors:  T Gordon; W B Kannel
Journal:  JAMA       Date:  1971-03-08       Impact factor: 56.272

5.  Atrial natriuretic factor receptor on cultured Leydig tumor cells: ligand binding and photoaffinity labeling.

Authors:  K N Pandey; T Inagami; K S Misono
Journal:  Biochemistry       Date:  1986-12-30       Impact factor: 3.162

6.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

7.  Dysregulation of atrial natriuretic factor in hypertension-prone man.

Authors:  P Ferrari; P Weidmann; C Ferrier; R Dietler; R Hollmann; R J Piso; J Wey; S Shaw
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

8.  Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes.

Authors:  M E Steinhelper; K L Cochrane; L J Field
Journal:  Hypertension       Date:  1990-09       Impact factor: 10.190

9.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

10.  Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA.

Authors:  K N Pandey; S Singh
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

View more
  162 in total

1.  A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21.

Authors:  D H Cohn; T Shohat; M Yahav; T Ilan; G Rechavi; L King; M Shohat
Journal:  Am J Hum Genet       Date:  2000-08-04       Impact factor: 11.025

Review 2.  Natriuretic peptide receptor: structure and signaling.

Authors:  Kunio S Misono
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

3.  Natriuretic peptide receptors and the heart.

Authors:  L King; M R Wilkins
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

4.  A friend within the heart: natriuretic peptide receptor signaling.

Authors:  Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 5.  Matrix metalloproteinases: pathways of induction by bioactive molecules.

Authors:  Toshihiro Tsuruda; Lisa C Costello-Boerrigter; John C Burnett
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

6.  In vitro aggregation of the regulated secretory protein chromogranin A.

Authors:  Renu K Jain; Wen Tzu Chang; Chitta Geetha; Paul B M Joyce; Sven-Ulrik Gorr
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

7.  Activation of IKK/NF-κB provokes renal inflammatory responses in guanylyl cyclase/natriuretic peptide receptor-A gene-knockout mice.

Authors:  Subhankar Das; Ramu Periyasamy; Kailash N Pandey
Journal:  Physiol Genomics       Date:  2012-02-07       Impact factor: 3.107

8.  Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.

Authors:  Marica Bordicchia; Dianxin Liu; Ez-Zoubir Amri; Gerard Ailhaud; Paolo Dessì-Fulgheri; Chaoying Zhang; Nobuyuki Takahashi; Riccardo Sarzani; Sheila Collins
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

9.  Internalization and trafficking of guanylyl (guanylate) cyclase/natriuretic peptide receptor A is regulated by an acidic tyrosine-based cytoplasmic motif GDAY.

Authors:  Kailash N Pandey; Huong T Nguyen; Renu Garg; Madan L Khurana; Jude Fink
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

10.  Inhibition of HDAC enhances STAT acetylation, blocks NF-κB, and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice.

Authors:  Prerna Kumar; Venkateswara R Gogulamudi; Ramu Periasamy; Giri Raghavaraju; Umadevi Subramanian; Kailash N Pandey
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.